In order to assess the clinical relevance of AGO1, AGO2 and Drosha as prognostic markers in bladder cancer patients, the Kaplan–Meier analyses of dichotomized immunoreactivity data were conducted. Here, AGO2 is linked to urinary bladder cancer.